Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study
重组亚单位结核病候选疫苗 GamTBvac 的安全性和免疫原性：一项 II 期、多中心、双盲、随机、安慰剂对照研究
期刊:Vaccines
影响因子:
doi:10.3390/vaccines8040652
Artem P Tkachuk, Evgeniia N Bykonia, Liubov I Popova, Denis A Kleymenov, Maria A Semashko, Vladimir P Chulanov, Sergey B Fitilev, Semyon L Maksimov, Elena A Smolyarchuk, Victor A Manuylov, Daria V Vasina, Vladimir A Gushchin, Alexander L Gintsburg
